Pipeline 2 Header

The weeklong Antibody Therapeutics pipeline reveals the exciting developments in next-generation antibody therapeutics, including Antibody-Drug Conjugates, Bispecific Antibody Therapeutics, and Cancer Immunotherapies. Along with engineering breakthroughs, this pipeline also explores successful R&D strategies, translational case studies, clinical results, and efficacy data for these promising molecules.

Conferences Include:

1月8日 - 9日

Engineering Next-Generation Cancer Immunotherapies ( 次世代癌症免疫疗法的开发 )

1月9日 - 10日

Antibody-Drug Conjugates ( 抗体药物复合物 )

1月11日 - 12日

Bispecific Antibody Therapeutics ( 双特异性抗体疗法 )